Microbot Medical (MBOT) Competitors $3.34 -0.08 (-2.34%) Closing price 04:00 PM EasternExtended Trading$3.36 +0.02 (+0.60%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MBOT vs. BVS, AVNS, ZIMV, KIDS, TMCI, CBLL, SMLR, DCTH, BFLY, and RXSTShould you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Bioventus (BVS), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), CeriBell (CBLL), Semler Scientific (SMLR), Delcath Systems (DCTH), Butterfly Network (BFLY), and RxSight (RXST). These companies are all part of the "medical equipment" industry. Microbot Medical vs. Its Competitors Bioventus AVANOS MEDICAL ZimVie OrthoPediatrics Treace Medical Concepts CeriBell Semler Scientific Delcath Systems Butterfly Network RxSight Microbot Medical (NASDAQ:MBOT) and Bioventus (NYSE:BVS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends. Which has more risk & volatility, MBOT or BVS? Microbot Medical has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, Bioventus has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Which has preferable earnings & valuation, MBOT or BVS? Microbot Medical has higher earnings, but lower revenue than Bioventus. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMicrobot MedicalN/AN/A-$11.44M-$0.58-5.76Bioventus$564.14M1.00-$156.23MN/AN/A Do analysts rate MBOT or BVS? Microbot Medical presently has a consensus target price of $12.00, indicating a potential upside of 259.28%. Bioventus has a consensus target price of $13.75, indicating a potential upside of 101.02%. Given Microbot Medical's higher probable upside, research analysts clearly believe Microbot Medical is more favorable than Bioventus.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Microbot Medical 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Bioventus 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Do insiders & institutionals believe in MBOT or BVS? 16.3% of Microbot Medical shares are owned by institutional investors. Comparatively, 62.9% of Bioventus shares are owned by institutional investors. 4.7% of Microbot Medical shares are owned by insiders. Comparatively, 33.0% of Bioventus shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is MBOT or BVS more profitable? Microbot Medical has a net margin of 0.00% compared to Bioventus' net margin of -7.11%. Bioventus' return on equity of 15.61% beat Microbot Medical's return on equity.Company Net Margins Return on Equity Return on Assets Microbot MedicalN/A -76.27% -67.54% Bioventus -7.11%15.61%4.01% Does the media favor MBOT or BVS? In the previous week, Microbot Medical had 10 more articles in the media than Bioventus. MarketBeat recorded 11 mentions for Microbot Medical and 1 mentions for Bioventus. Bioventus' average media sentiment score of 1.74 beat Microbot Medical's score of 0.55 indicating that Bioventus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 4 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bioventus 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryBioventus beats Microbot Medical on 8 of the 14 factors compared between the two stocks. Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBOT vs. The Competition Export to ExcelMetricMicrobot MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$155.77M$6.74B$5.73B$10.31BDividend YieldN/A1.21%5.90%4.63%P/E Ratio-5.7626.6075.8626.51Price / SalesN/A194.74528.72123.58Price / CashN/A21.6137.1760.46Price / Book19.654.9412.796.29Net Income-$11.44M$176.38M$3.28B$270.51M7 Day Performance-13.25%4.79%0.22%2.15%1 Month Performance8.09%7.07%4.61%6.35%1 Year Performance247.92%10.43%68.33%25.48% Microbot Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBOTMicrobot Medical2.3054 of 5 stars$3.34-2.3%$12.00+259.3%+245.5%$155.77MN/A-5.7620News CoverageAnalyst UpgradeGap UpBVSBioventus3.2991 of 5 stars$7.21+0.3%$13.75+90.7%-35.8%$596.12M$564.14M-11.821,200Positive NewsAVNSAVANOS MEDICAL1.7824 of 5 stars$12.41-2.5%N/A-48.8%$590.24M$687.80M-1.232,227News CoveragePositive NewsZIMVZimVie1.2078 of 5 stars$18.89+0.2%$17.75-6.0%+14.8%$531.77M$449.75M-26.991,770Positive NewsKIDSOrthoPediatrics4.3299 of 5 stars$20.91flat$34.14+63.3%-39.4%$524.29M$204.73M-11.68200TMCITreace Medical Concepts2.3711 of 5 stars$7.11-0.8%$9.83+38.3%+41.0%$452.95M$209.36M-9.00250CBLLCeriBell2.5225 of 5 stars$12.06+2.2%$32.14+166.5%N/A$432.64M$65.44M-4.03N/APositive NewsSMLRSemler Scientific2.9458 of 5 stars$28.29+0.6%$81.75+189.0%+9.5%$416.31M$56.29M3.34120DCTHDelcath Systems3.0414 of 5 stars$11.55-0.9%$24.50+112.1%+11.8%$407.53M$37.21M231.0060Positive NewsBFLYButterfly Network3.25 of 5 stars$1.60+2.2%$3.00+88.1%-13.8%$392.72M$82.06M-5.70460Positive NewsRXSTRxSight1.9964 of 5 stars$8.94+0.6%$10.00+11.9%-83.2%$363.74M$139.93M-11.18220Trending News Related Companies and Tools Related Companies Bioventus Alternatives AVANOS MEDICAL Alternatives ZimVie Alternatives OrthoPediatrics Alternatives Treace Medical Concepts Alternatives CeriBell Alternatives Semler Scientific Alternatives Delcath Systems Alternatives Butterfly Network Alternatives RxSight Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MBOT) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBOT Stock Alerts